Author pages are created from data sourced from our academic publisher partnerships and public sources.
Preclinical Study on GRPR-Targeted (68)Ga-Probes for PET Imaging of Prostate Cancer.
Gastrin-releasing peptide receptor (GRPR) targeted positron emission tomography (PET) is a highly promising approach for imaging of prostate cancer (PCa) in small animal models and patients.… Expand
The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy.
BACKGROUND It can be challenging to predict the risk of biochemical recurrence (BR) during follow-up after radical prostatectomy (RP) in men who have undetectable prostate-specific antigen (PSA),… Expand
Improved positron emission tomography imaging of glioblastoma cancer using novel 68Ga-labeled peptides targeting the urokinase-type plasminogen activator receptor (uPAR)
The urokinase-type plasminogen activator receptor (uPAR) is overexpressed in several cancers including glioblastoma (GBM) and is an established biomarker for metastatic potential. The uPAR-targeting… Expand
Temporal Trends in Clinical and Pathological Characteristics for Men Undergoing Radical Prostatectomy Between 1995 and 2013 at Rigshospitalet, Copenhagen, Denmark, and Stanford University Hospital,…
- Mathias Loft, K. D. Berg, +6 authors Martin Andreas R&phgr;der
- Clinical genitourinary cancer
- 6 September 2017
Purpose To analyze how prostate‐specific antigen (PSA) screening and practice patterns has affected trends in tumor characteristics in men undergoing radical prostatectomy (RP) in the United States… Expand
64Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine Neoplasms
- E. Carlsen, C. B. Johnbeck, +9 authors A. Kjaer
- The Journal of Nuclear Medicine
- 28 February 2020
Overexpression of somatostatin receptors (SSTRs) in patients with neuroendocrine neoplasms (NENs) is used for both diagnosis and treatment. Receptor density may reflect tumor differentiation and thus… Expand
Multimodality Hyperpolarized C-13 MRS/PET/Multiparametric MR Imaging for Detection and Image-Guided Biopsy of Prostate Cancer: First Experience in a Canine Prostate Cancer Model
- S. Bachawal, J. M. Park, +10 authors J. K. Willmann
- Molecular Imaging and Biology
- 21 February 2019
PurposeTo assess whether simultaneous hyperpolarized C-13 magnetic resonance spectroscopy (MRS)/positron emission tomography (PET)/multiparametric magnetic resonance (mpMR) imaging is feasible in an… Expand
Synthesis and Evaluation of (68)Ga-labeled uPAR Targeted Peptides for PET Imaging of Glioblastoma
64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection
64Cu-DOTATATE PET/CT imaging 1 h after injection is excellent for lesion detection in patients with neuroendocrine neoplasms (NENs). We hypothesized that the imaging time window can be extended up to… Expand
The CPC risk calculator app: A validated tool to predict recurrence after radical prostatectomy.
INTRODUCTION & OBJECTIVES: No contemporary nomogram to help predict biochemical recurrence (BR) after radical prostatectomy (RP) using a combination of competing risk assessment and conditional… Expand